RB Capital Management LLC Grows Stake in HCA Healthcare, Inc. $HCA

RB Capital Management LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,012 shares of the company’s stock after acquiring an additional 40 shares during the period. RB Capital Management LLC’s holdings in HCA Healthcare were worth $1,041,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. GAMMA Investing LLC boosted its position in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock valued at $5,887,850,000 after buying an additional 1,699,713 shares during the last quarter. Nuveen LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at $569,217,000. Pacer Advisors Inc. boosted its position in shares of HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after buying an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have issued reports on HCA shares. Truist Financial raised their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Barclays dropped their target price on HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating on the stock in a research report on Monday, July 28th. Wells Fargo & Company decreased their price objective on HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 14th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Finally, Morgan Stanley decreased their target price on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a research note on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $401.83.

HCA Healthcare Stock Performance

NYSE:HCA opened at $401.72 on Wednesday. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock’s 50 day simple moving average is $375.19 and its two-hundred day simple moving average is $355.12. The company has a market cap of $94.00 billion, a price-to-earnings ratio of 16.89, a PEG ratio of 1.27 and a beta of 1.39.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.